Fragile neutrophils in surgical patients: A phenomenon associated with critical illness.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
30
03
2020
accepted:
08
07
2020
entrez:
5
8
2020
pubmed:
5
8
2020
medline:
9
10
2020
Statut:
epublish
Résumé
Leukocyte viability (determined by e.g. propidium iodide [PI] staining) is automatically measured by hematology analyzers to check for delayed bench time. Incidental findings in fresh blood samples revealed the existence of leukocytes with decreased viability in critically ill surgical patients. Not much is known about these cells and their functional and/or clinical implications. Therefore, we investigated the incidence of decreased leukocyte viability, the implications for leukocyte functioning and its relation with clinical outcomes. An automated alarm was set in a routine hematology analyzer (Cell-Dyn Sapphire) for the presence of non-viable leukocytes characterized by increased fluorescence in the PI-channel (FL3:630±30nm). Patients with non-viable leukocytes were prospectively included and blood samples were drawn to investigate leukocyte viability in detail and to investigate leukocyte functioning (phagocytosis and responsiveness to a bacterial stimulus). Then, a retrospective analysis was conducted to investigate the incidence of fragile neutrophils in the circulation and clinical outcomes of surgical patients with fragile neutrophils hospitalized between 2013-2017. A high FL3 signal was either caused by 1) neutrophil autofluorescence which was considered false positive, or by 2) actual non-viable PI-positive neutrophils in the blood sample. These two causes could be distinguished using automatically generated data from the hematology analyzer. The non-viable (PI-positive) neutrophils proved to be viable (PI-negative) in non-lysed blood samples, and were therefore referred to as 'fragile neutrophils'. Overall leukocyte functioning was not impaired in patients with fragile neutrophils. Of the 11 872 retrospectively included surgical patients, 75 (0.63%) were identified to have fragile neutrophils during hospitalization. Of all patients with fragile neutrophils, 75.7% developed an infection, 70.3% were admitted to the ICU and 31.3% died during hospitalization. In conclusion, fragile neutrophils occur in the circulation of critically ill surgical patients. These cells can be automatically detected during routine blood analyses and are an indicator of critical illness.
Identifiants
pubmed: 32750099
doi: 10.1371/journal.pone.0236596
pii: PONE-D-20-09054
pmc: PMC7402494
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0236596Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Immunol Methods. 2015 Aug;423:99-103
pubmed: 25975759
J Leukoc Biol. 2008 Apr;83(4):799-803
pubmed: 18063695
Crit Care Med. 2002 Feb;30(2):315-22
pubmed: 11889301
Clin Chem. 2008 May;54(5):911-5
pubmed: 18443177
Crit Care. 2017 Jan 24;21(1):14
pubmed: 28118843
Shock. 2008 Dec;30(6):618-22
pubmed: 18496237
Cell Death Differ. 2004 Jul;11 Suppl 1:S45-55
pubmed: 15243581
Virology. 2016 Dec;499:23-29
pubmed: 27632562
Nat Protoc. 2006;1(3):1458-61
pubmed: 17406435
Braz J Med Biol Res. 2010 Sep;43(9):853-8
pubmed: 20721471
Lab Hematol. 2006;12(1):15-31
pubmed: 16513543
Shock. 2008 Oct;30(4):352-8
pubmed: 18317404
Arch Intern Med. 2000 Nov 27;160(21):3326-7
pubmed: 11088097
Clin Chem Lab Med. 2007;45(1):13-9
pubmed: 17243908
Mediators Inflamm. 2012;2012:509513
pubmed: 22523451
J Leukoc Biol. 2010 Jul;88(1):211-20
pubmed: 20400675
Shock. 2006 Sep;26(3):254-61
pubmed: 16912650
Ann Surg. 2017 Jun;265(6):1241-1249
pubmed: 27232244
Am J Hematol. 2015 Jul;90(7):679-80
pubmed: 25611203
Eur Neuropsychopharmacol. 2013 Nov;23(11):1408-13
pubmed: 24074821
J Immunol Methods. 1999 Dec 17;232(1-2):211-29
pubmed: 10618522
Arch Pathol Lab Med. 2000 Sep;124(9):1291-4
pubmed: 10975923
Am J Clin Pathol. 1990 May;93(5):662-9
pubmed: 2327366
Blood. 2017 Jun 29;129(26):3476-3485
pubmed: 28515092
Pediatr Emerg Care. 2008 Nov;24(11):745-8
pubmed: 18955911
J Vis Exp. 2016 Sep 12;(115):
pubmed: 27684595
Lab Hematol. 2004;10(2):68-73
pubmed: 15224762
JNMA J Nepal Med Assoc. 2008 Apr-Jun;47(170):82-5
pubmed: 18709037
Curr Protoc Cytom. 2010 Jul;Chapter 9:Unit 9.34
pubmed: 20578108
Clin Chem Lab Med. 2009;47(8):903-16
pubmed: 19642859
J Cell Biol. 1993 Jan;120(2):545-56
pubmed: 7678422
J Leukoc Biol. 2006 Apr;79(4):828-36
pubmed: 16461736
J Clin Invest. 1967 Dec;46(12):1943-53
pubmed: 6073999
Eur Surg. 2018;50(6):256-261
pubmed: 30546385
Cells. 2013 Mar 26;2(2):202-23
pubmed: 24709697
Clin Chem Lab Med. 2015 Jun;53(7):1057-71
pubmed: 25720071
J Exp Med. 1969 Feb 1;129(2):267-93
pubmed: 5762047
Nat Protoc. 2016 Apr;11(4):655-63
pubmed: 26938116
Clin Lab Haematol. 2004 Jun;26(3):177-86
pubmed: 15163315
J Biomed Opt. 2008 Sep-Oct;13(5):054057
pubmed: 19021436
Cold Spring Harb Protoc. 2016 Nov 1;2016(11):
pubmed: 27803250
Immunology. 2008 Nov;125(3):281-8
pubmed: 19128361
Methods. 2018 Feb 1;134-135:149-163
pubmed: 29269150
Asian Pac J Cancer Prev. 2016;17(4):1847-50
pubmed: 27221863
Cent Eur J Immunol. 2018;43(2):168-173
pubmed: 30135629
Clin Lab Haematol. 1998 Feb;20(1):21-9
pubmed: 9681207
J Clin Oncol. 2009 Apr 10;27(11):1844-9
pubmed: 19255329
Front Microbiol. 2017 Dec 14;8:2491
pubmed: 29312199